1. Home
  2. SID vs MRVI Comparison

SID vs MRVI Comparison

Compare SID & MRVI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Companhia Siderurgica Nacional S.A.

SID

Companhia Siderurgica Nacional S.A.

HOLD

Current Price

$0.89

Market Cap

1.2B

Sector

Industrials

ML Signal

HOLD

Logo Maravai LifeSciences Holdings Inc.

MRVI

Maravai LifeSciences Holdings Inc.

HOLD

Current Price

$5.80

Market Cap

1.0B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SID
MRVI
Founded
1941
2014
Country
Brazil
United States
Employees
N/A
N/A
Industry
Steel/Iron Ore
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.2B
1.0B
IPO Year
2002
2020

Fundamental Metrics

Financial Performance
Metric
SID
MRVI
Price
$0.89
$5.80
Analyst Decision
Strong Sell
Buy
Analyst Count
1
4
Target Price
$1.40
$4.13
AVG Volume (30 Days)
4.4M
2.2M
Earning Date
05-06-2026
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
14.29
EPS
N/A
N/A
Revenue
N/A
$185,743,000.00
Revenue This Year
$1.71
$12.54
Revenue Next Year
$1.58
$7.87
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.84
$2.29
52 Week High
$2.20
$7.44

Technical Indicators

Market Signals
Indicator
SID
MRVI
Relative Strength Index (RSI) 37.56 36.84
Support Level $0.88 $5.67
Resistance Level $1.06 $6.55
Average True Range (ATR) 0.06 0.34
MACD -0.01 -0.15
Stochastic Oscillator 18.91 24.84

Price Performance

Historical Comparison
SID
MRVI

About SID Companhia Siderurgica Nacional S.A.

Companhia Siderurgica Nacional is an integrated steel producer. together with its subsidiaries operates in five main business segments: Steel industry: production and marketing of flat and long steels; Mining: extraction, processing and marketing of iron ore, tin, limestone and dolomite; Cement: production and commercialization of bagged and bulk cement, in addition to aggregates, concrete, and other related products; Energy: generation and sale of energy from almost all renewable sources; and Logistics: participations port concessions and fleets of road transport vehicles. The group generates the majority of its revenue from the Steel industry segment. Geographically, it derives a majority of revenue from Asia.

About MRVI Maravai LifeSciences Holdings Inc.

Maravai LifeSciences Holdings Inc is a life sciences company providing products and services to enable the development of drugs, therapeutics, vaccines and diagnostics, and to support research on human disease. Its product portfolio includes complex nucleic acids, custom enzymes and antibody-based solutions for therapeutic, vaccine, diagnostic and biopharmaceutical production applications. The Company operates through two segments: TriLink, which generates maximum revenue from North America and provides nucleic acid products and services including mRNA, oligonucleotides and related technologies; and Cygnus, which provides biologics safety testing products and services including host cell protein ELISA kits, impurity detection assays and related reagents and services.

Share on Social Networks: